Oncology studies present unique challenges when it comes to participant treatmen...
Clinical trial complexity has significantly increased in the past decade. How ca...
E. Merck KG board of partners has announced the appointment of new CEOs to Merck...
The FDA has accepted Gilead’s new drug application with a decision expected by 1...
Product sales for the vaccine specialist Valneva reached €170m despite slow US s...
The EC has conditionally approved MSD's Welireg as a single agent for the treatm...
Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024, a shar...
Wide areas of the pharmaceutical industry are ripe for enhancement, as examples ...
Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for...
US President Donald Trump kicked off his second term with a series of directives...
SmartCella has secured exclusive rights to advance research around cell replacem...
CSL has received approval from the EC for Andembry (garadacimab) to prevent recu...
The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (...
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s firs...
New EU regulations aim to speed up health technology assessments (HTAs), but the...
Newleos has closed an oversubscribed Series A financing round, raising $93.5m to...
